Scarica l'app Stockscreener
4.01
2.04%
0.08
Dopo l'orario di chiusura:
4.02
0.010
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.93
Aprire:
$3.95
Volume 24 ore:
1.04M
Relative Volume:
1.31
Capitalizzazione di mercato:
$768.71M
Reddito:
$12.99M
Utile/perdita netta:
$-74.39M
Rapporto P/E:
-9.1136
EPS:
-0.44
Flusso di cassa netto:
$-78.92M
1 W Prestazione:
+9.26%
1M Prestazione:
+20.06%
6M Prestazione:
+18.29%
1 anno Prestazione:
-1.96%
Intervallo 1D:
$3.88
$4.03
Intervallo di 1 settimana:
$3.65
$4.095
Portata 52W:
$2.705
$4.725
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Nome
Arbutus Biopharma Corp
Settore
Industria
Telefono
604-419-3200
Indirizzo
701 VETERANS CIRCLE, WARMINSTER, PA
Confronta ABUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.01 | 732.29M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-02-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Iniziato | Jefferies | Hold |
| 2020-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-27 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-07-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-03-06 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-05 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Reiterato | B. Riley FBR | Buy |
| 2019-10-04 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2018-10-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-06 | Downgrade | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Ripresa | Chardan Capital Markets | Buy |
| 2018-03-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Reiterato | Wedbush | Outperform |
| 2016-12-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
Mostra tutto
Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie
Should value investors consider Arbutus Biopharma CorporationEarnings Risk Report & Expert Verified Stock Movement Alerts - khodrobank.com
Analyzing recovery setups for Arbutus Biopharma Corporation investorsRate Cut & Free Weekly Watchlist of Top Performers - Newser
Is Arbutus Biopharma Corporation vulnerable to short sellersMarket Movement Recap & Daily Profit Maximizing Tips - khodrobank.com
Using flow based indicators on Arbutus Biopharma CorporationJuly 2025 Levels & Verified Chart Pattern Signals - Newser
Using data models to predict Arbutus Biopharma Corporation stock movementMarket Performance Summary & Daily Entry Point Alerts - Newser
Published on: 2025-09-03 05:15:59 - Newser
Chart based analysis of Arbutus Biopharma Corporation trendsOptions Play & Low Drawdown Investment Ideas - Newser
Tools to monitor Arbutus Biopharma Corporation recovery probability2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
What MACD and RSI say about Arbutus Biopharma CorporationMarket Performance Summary & Advanced Technical Analysis Signals - Newser
Can Arbutus Biopharma Corporation sustain earnings growth2025 Growth vs Value & Trade Opportunity Analysis - khodrobank.com
Arbutus Biopharma Corporation’s volatility index tracking explained2025 Performance Recap & Risk Managed Trade Strategies - Newser
Custom watchlist performance reports with Arbutus Biopharma CorporationWeekly Trend Recap & Stock Portfolio Risk Control - Newser
Volume spikes in Arbutus Biopharma Corporation stock – what they meanPortfolio Value Summary & High Conviction Investment Ideas - Newser
Is Arbutus Biopharma Corporation trending in predictive chart modelsJuly 2025 Summary & Daily Stock Trend Reports - Newser
Arbutus Biopharma Corporation stock daily chart insights2025 Market Trends & Low Risk High Win Rate Stock Picks - Newser
Nuveen LLC Invests $1.09 Million in Arbutus Biopharma Corporation $ABUS - Defense World
How to read the order book for Arbutus Biopharma CorporationJuly 2025 Setups & AI Forecast Swing Trade Picks - Newser
Is Arbutus Biopharma Corporation undervalued by DCF analysisMarket Growth Report & Reliable Price Breakout Signals - khodrobank.com
How to build a custom watchlist for Arbutus Biopharma CorporationJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year? - ca.finance.yahoo.com
Is Arbutus Biopharma Corporation on track to beat earningsJuly 2025 Technicals & Fast Entry and Exit Trade Plans - khodrobank.com
Can swing trading help recover from Arbutus Biopharma Corporation lossesMarket Volume Summary & Safe Capital Growth Trade Ideas - Newser
Technical analysis overview for Arbutus Biopharma Corporation stock - Newser
Measuring Arbutus Biopharma Corporation’s beta against major indicesPrice Action & Weekly Market Pulse Alerts - Newser
Published on: 2025-08-30 22:10:35 - Newser
Applying sector rotation models to Arbutus Biopharma CorporationWeekly Trend Recap & Technical Confirmation Alerts - Newser
Developing predictive dashboards with Arbutus Biopharma Corporation dataMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Real time scanner hits for Arbutus Biopharma Corporation explainedJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Technical signs of recovery in Arbutus Biopharma Corporation2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Arbutus Biopharma Corporation stock outlook for YEARMarket Rally & Weekly Stock Performance Updates - Newser
Key metrics from Arbutus Biopharma Corporation’s quarterly data2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):